Breakthrough Assay for Detecting RNA-Associated Glycan Signals

A new publication in Biosensors and Bioelectronics introduces the NHAPL platform, a homogeneous assay that enables sensitive and quantitative analysis of RNA-associated glycan signals from total cell RNA and serum samples. The work, led by researchers including Jie Gui, Meng Zhang, Ziwei Kan, Xiaojuan He, Meipei Gao, Jian Han, Qiongfang Wang, Shengyao Zhang, Junyi Hu, Wenyi Qin, Zi Bi, Boyue Huang, Zhongjun Wu, and Jianhua Ran, details how this method combines nucleotide hybridization with an aptamer-based approach for dual recognition of RNA and glycan components.

The full details appear in the original publication available at https://www.sciencedirect.com/science/article/abs/pii/S0956566326005725. This development addresses longstanding challenges in studying glycoRNAs, which are RNA molecules bearing glycan modifications.

Understanding GlycoRNAs and Their Biological Significance

GlycoRNAs represent an emerging class of biomolecules where RNA molecules carry attached glycan structures, primarily sialic acid and fucose residues. These modifications occur on various RNA types, including small noncoding RNAs such as tRNAs, Y RNAs, snRNAs, and miRNAs. Research indicates that glycoRNAs are displayed on cell surfaces and participate in cell communication, immune regulation, and interactions with proteins like Siglecs and P-selectin.

Earlier observations linked glycan-related signals mainly to small noncoding RNAs, but the new findings extend this to certain messenger RNA fragments. The presence of these modified RNAs on cell membranes suggests roles in processes ranging from adhesion to migration and potential involvement in disease states.

Limitations of Existing Detection Methods

Prior techniques for studying glycoRNAs relied on metabolic labeling, chemoenzymatic strategies, or in situ visualization. These approaches often required specialized equipment, extensive sample processing, or were limited to qualitative observations rather than quantitative multiplexed analysis in complex samples like serum.

Methods such as mass spectrometry or gel blotting provided structural insights but struggled with low-abundance species or required enrichment steps that could introduce biases. The absence of a simple, homogeneous assay for individual glycoRNA species quantification hindered broader exploration of their roles in health and disease.

The NHAPL Platform: Design and Mechanism

NHAPL stands for Nucleotides Hybridization and Aptamer-based Proximity Ligation. It adapts the proximity ligation assay principle, where two binding events in close proximity trigger ligation of DNA probes to create an amplifiable reporter molecule detected via quantitative PCR.

The assay integrates a sialic acid-specific aptamer for glycan recognition with complementary DNA probes that bind the RNA portion. A connector oligonucleotide facilitates ligation upon dual binding, generating a DNA template for qPCR amplification. This produces measurable cycle threshold values that correlate with the abundance of target RNA-associated glycan signals.

The platform operates without specialized instrumentation beyond standard qPCR equipment, making it accessible for many laboratories. It supports multiplexed detection by designing probes for multiple targets simultaneously.

Validation Using Cell Culture Models

Researchers validated NHAPL with total RNA extracted from cultured cells, including THP-1 and Hep3B lines. The method successfully detected signals associated with specific 3′UTR fragments from FNDC3B and CTSS genes.

These findings suggest that certain membrane-associated nuclear-encoded RNAs may carry glycan modifications, broadening the known scope beyond small noncoding RNAs. Functional experiments involving perturbation of these species indicated connections to cellular behaviors such as adhesion in THP-1 cells and migration in Hep3B cells.

Photo by Vitaly Gariev on Unsplash

Multiplexed Detection Capabilities

Building on the core assay, the team established multiplexed NHAPL for simultaneous measurement of multiple RNA-associated glycan signals. This capability allows efficient profiling in a single reaction, reducing sample requirements and processing time compared to sequential single-target assays.

The approach maintains sensitivity and specificity while enabling researchers to examine patterns across several targets, which is valuable for understanding coordinated biological roles or identifying disease signatures.

Applications in Human Serum and Disease Biomarker Potential

Testing extended to human serum samples, where RNA-associated glycan signals exhibited relatively low variability among healthy individuals. In contrast, signals linked to Y5 and U1 RNAs showed marked elevations in patients with systemic lupus erythematosus.

Performance metrics included an area under the receiver operating characteristic curve of 1.000 for Y5-associated signals and 0.9977 for U1-associated signals within the studied cohort. These results highlight the platform's potential for identifying candidate biomarkers in autoimmune conditions.

The homogeneous format simplifies analysis of minimally processed serum, supporting future clinical translation efforts.

Advantages Over Traditional Approaches

NHAPL offers several practical benefits: it requires no specialized instrumentation, supports rapid multiplexed analysis, and works with complex biological matrices. The reliance on aptamer and hybridization probes provides flexibility for targeting different glycan-RNA combinations.

By converting biological recognition events into quantifiable DNA amplicons, the method achieves high sensitivity suitable for low-abundance targets. Its simplicity positions it as a versatile tool for both basic research and applied studies in glycobiology and RNA biology.

Implications for Academic Research and Biomedical Fields

This publication contributes to the growing field of glycoRNA research by providing a practical tool for quantitative analysis. Laboratories focused on molecular diagnostics, immunology, and RNA modifications can adopt the method to explore new questions about cell surface glycoconjugates.

The work also underscores connections between RNA modifications and disease processes, opening avenues for interdisciplinary studies involving chemistry, biology, and clinical sciences. Academic institutions may see increased interest in related training programs and collaborative projects.

Future Directions and Research Opportunities

Further optimization could expand the range of detectable glycan types or integrate with other amplification strategies. Large-scale cohort studies will be needed to confirm biomarker utility across diverse populations.

Researchers interested in advancing this area may explore applications in additional disease models or combine NHAPL with sequencing technologies for deeper molecular insights. The platform's design encourages adaptation for various experimental needs in academic and translational settings.

Photo by Vitaly Gariev on Unsplash

Relevance to the Broader Scientific Community

Publications like this one highlight ongoing innovation in biosensor development and analytical chemistry. They provide concrete examples of how proximity-based techniques can be tailored for emerging biomolecular targets.

Professionals tracking developments in biosensors and bioelectronics will find value in the detailed methodology and performance data presented. The emphasis on accessibility supports wider adoption in resource-diverse research environments.